Raffa Wealth Management’s Avanos Medical AVNS Stock Holding History

Raffa Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-803	Closed	-$16K	–	1092
2024 Q2	$16K	Hold	803	–	–	﹤0.01%	368
2024 Q1	$16K	Buy	+803	New	+$15.5K	﹤0.01%	350
2017 Q1	–	Sell	-1	Closed	-$37	–	415
2016 Q4	$37	Hold	1	–	–	﹤0.01%	881
2016 Q3	$35	Hold	1	–	–	﹤0.01%	867
2016 Q2	$33	Hold	1	–	–	﹤0.01%	862
2016 Q1	$29	Hold	1	–	–	﹤0.01%	849
2015 Q4	$33	Hold	1	–	–	﹤0.01%	849
2015 Q3	$28	Hold	1	–	–	﹤0.01%	841
2015 Q2	$41	Hold	1	–	–	﹤0.01%	825
2015 Q1	$49	Hold	1	–	–	﹤0.01%	809
2014 Q4	$45	Buy	+1	New	+$39	﹤0.01%	751

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Raffa Wealth Management's AVNS Position: Q3 2024 in Review

Raffa Wealth Management sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 803 shares — an estimated $16K sold.

Raffa Wealth Management first reported a position in AVNS in Q4 2014 and held it in 11 quarters. The position peaked at $16K in Q2 2024. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

Raffa Wealth Management reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
Raffa Wealth Management sold 803 Avanos Medical shares in Q3 2024, an estimated $16K.
Raffa Wealth Management first reported a position in Avanos Medical in Q4 2014 and held it in 11 quarters.
Raffa Wealth Management's Avanos Medical position peaked at $16K in Q2 2024.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on Raffa Wealth Management's 13F filing for Q3 2024, filed 27 Jul 2026.